Red Blood Cell Distribution Width and Charlson Comorbidity Indeces in the Frail Polytraumatized Patient.

In this study patients who were admitted to our hospital with critical injuries were enrolled retrospectively from January 2012 to December 2015. Patients with an ISS>16 points, an AIS >3 in one body region and at least 2 different body regions affected were included. RDW values on admission as well as preexisting comorbidities were evaluated.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Polytrauma Comorbidities and Coexisting Conditions Multiple Trauma Red Blood Cell Distribution Width Wounds and Injuries

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

ISS >16 points
AIS >3 in one body region
at least 2 body regions affected

Exclusion criteria

patients younger than 18 years of age
isolated traumatic brain injury
minor injuries (AIS <3 or ISS <16 points)

Treatment and study plan

retrospective

Other

The investigators retrospectively analyzed the short- and long-term outcome in polytraumatized patients and the possible influence of RDW values on admission as well as preexisting comorbidities on these outcomes.

Primary outcomes

In-hospital mortality in polytraumatized patients

Time frame: January 2012 to December 2015

Secondary outcomes

Possible influence of RDW values (%) on admission on the long-term outcome

Time frame: January 2012 to December 2015

The influence of RDW Values (%) in polytraumatized patients on admission on the long-term outcome (late-phase death (days)) will be examined.

Sponsors and collaborators

Lead sponsor

Medical University of Vienna

Other

Registry information

Official study title

RDW and CCI in the Frail Polytraumatized Patients. A Retrospective Cohort Study in a Level 1 Trauma Center.

Important dates

Study start: 2012
Primary completion: 2015
Study completion: 2015
First posted: Feb 3, 2022
Registry last updated: Nov 25, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed